| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine-Hypertension Division and Departments of Medicine (O.K., I.K., R.R.B., E.M.B.) and Surgery (F.D.M.), Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 02115; and Scantibodies Laboratories (T.C., P.G.), Santee, California 92071
Address all correspondence and requests for reprints to: Dr. Olga Kifor, Endocrine-Hypertension Division, Brigham and Womens Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115. E-mail: okifor{at}rics.bwh.harvard.edu.
Caveolins are key components of caveolae membranes. The calcium-sensing receptor (CaR) resides within caveolin-rich membrane domains in bovine parathyroid (PT) cells. Recent studies reported reduced CaR expression, and abnormal calcium-sensing in PT tumors. To examine this altered CaR signaling, we investigated ERK activation after CaR stimulation in human and bovine PT cells. In freshly prepared bovine PT cells, high extracellular calcium (Ca2+0) stimulates ERK1/2 phosphorylation, and activated ERK1/2 colocalizes with caveolin-1 at the plasma membrane but fails to translocate to the nucleus, and cell proliferation is low. In cultured bovine PT cells, CaR and caveolin-1 levels are reduced; activated ERK1/2 localizes in the cell periphery at 10 min and in the perinuclear and nuclear regions at 60 min after exposure to high Ca2+0, and cell proliferation is increased. In PT cells from adenomas, there are high levels of caveolin-2, variably reduced caveolin-1, and hyperactivation of ERK1/2, which colocalizes with caveolin-1 in some cells, but localizes in the cytosol and nucleus in others. Finally, caveolin-1 negative human PT cells exhibit reduced suppressibility of PTH secretion by high Ca2+0. Thus, CaR and caveolin-1 colocalize in PT cells, and reduced levels of caveolin-1 could participate in the abnormal cellular function and proliferation of cultured bovine PT cells and PT adenomas.
This work was supported by generous grants from the NIH (DK41415, 48330, and 52005), NPS Pharmaceuticals, and the St. Giles Foundation.
Abbreviations: BrdU, 5-Bromo-2'-deoxy-uridine; Ca2+0, extracellular calcium; CaR, calcium-sensing receptor; Elk-1, Ets-like protein-1; HEK293, human embryonic kidney (cells); HEKCaR, CaR-transfected HEK293 cells; MBS, 2-(N-morpholino)-ethanesulfonic acid-buffered saline; pElk-1, phosphorylated Elk-1; pERK1/2, phosphorylated ERK1/2; PKC, protein kinase C; PLA2, phospholipase A2; PT, parathyroid; SDS, sodium dodecyl sulfate.
This article has been cited by other articles:
![]() |
R. Gosens, G. Dueck, W. T. Gerthoffer, H. Unruh, J. Zaagsma, H. Meurs, and A. J. Halayko p42/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1163 - L1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Costa, M. Senou, F. Van Rode, J. Ruf, M. Capello, D. Dequanter, P. Lothaire, C. Dessy, J. E. Dumont, M.-C. Many, et al. Reciprocal Negative Regulation between Thyrotropin/3',5'-Cyclic Adenosine Monophosphate-Mediated Proliferation and Caveolin-1 Expression in Human and Murine Thyrocytes Mol. Endocrinol., April 1, 2007; 21(4): 921 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Syme, L. Zhang, and A. Bisello Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Chen and W. G. Goodman Role of the calcium-sensing receptor in parathyroid gland physiology Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1005 - F1011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |